134 related articles for article (PubMed ID: 8180384)
1. Effect of granulocyte-macrophage colony-stimulating factor on sepsis-induced organ injury in rats.
Toda H; Murata A; Oka Y; Uda K; Tanaka N; Ohashi I; Mori T; Matsuura N
Blood; 1994 May; 83(10):2893-8. PubMed ID: 8180384
[TBL] [Abstract][Full Text] [Related]
2. Granulocyte macrophage colony-stimulating factor improves survival in two models of gut-derived sepsis by improving gut barrier function and modulating bacterial clearance.
Gennari R; Alexander JW; Gianotti L; Eaves-Pyles T; Hartmann S
Ann Surg; 1994 Jul; 220(1):68-76. PubMed ID: 8024361
[TBL] [Abstract][Full Text] [Related]
3. Granulocyte-macrophage-colony-stimulating factor-dependent peritoneal macrophage responses determine survival in experimentally induced peritonitis and sepsis in mice.
Spight D; Trapnell B; Zhao B; Berclaz P; Shanley TP
Shock; 2008 Oct; 30(4):434-42. PubMed ID: 18277945
[TBL] [Abstract][Full Text] [Related]
4. Control of fecal peritoneal infection in mice by colony-stimulating factors.
Barsig J; Bundschuh DS; Hartung T; Bauhofer A; Sauer A; Wendel A
J Infect Dis; 1996 Oct; 174(4):790-9. PubMed ID: 8843218
[TBL] [Abstract][Full Text] [Related]
5. Hematologic effects of recombinant murine granulocyte-macrophage colony-stimulating factor on the peripheral blood and bone marrow.
Ulich TR; del Castillo J; McNiece I; Watson L; Yin SM; Andresen J
Am J Pathol; 1990 Aug; 137(2):369-76. PubMed ID: 1696784
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.
Root RK; Dale DC
J Infect Dis; 1999 Mar; 179 Suppl 2():S342-52. PubMed ID: 10081506
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of peritoneal leukocyte function by granulocyte colony-stimulating factor in rats with abdominal sepsis.
Zhang P; Bagby GJ; Stoltz DA; Summer WR; Nelson S
Crit Care Med; 1998 Feb; 26(2):315-21. PubMed ID: 9468171
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic efficacy of granulocyte colony stimulating factor against rat cecal ligation and puncture model.
Toda H; Murata A; Matsuura N; Uda K; Oka Y; Tanaka N; Mori T
Stem Cells; 1993 May; 11(3):228-34. PubMed ID: 7686420
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia.
Bilgin K; Yaramiş A; Haspolat K; Taş MA; Günbey S; Derman O
Pediatrics; 2001 Jan; 107(1):36-41. PubMed ID: 11134431
[TBL] [Abstract][Full Text] [Related]
10. Recombinant GM-CSF enhances the bactericidal ability of PMNs by increasing intracellular IL-1β and improves the prognosis of secondary Pseudomonas aeruginosa pneumonia in sepsis.
Tu F; Pan L; Wu W; Cai Y; Li J; Wang X; Lai X; Chen Z; Ye L; Wang S
J Leukoc Biol; 2023 Oct; 114(5):443-458. PubMed ID: 37490847
[TBL] [Abstract][Full Text] [Related]
11. Recombinant murine granulocyte-macrophage colony-stimulating factor augments neutrophil recovery and enhances resistance to infections in myelosuppressed mice.
Mayer P; Schütze E; Lam C; Kricek F; Liehl E
J Infect Dis; 1991 Mar; 163(3):584-90. PubMed ID: 1995731
[TBL] [Abstract][Full Text] [Related]
12. The ability of recombinant murine granulocyte-macrophage colony-stimulating factor to protect neonatal rats from septic death due to Staphylococcus aureus.
Frenck RW; Sarman G; Harper TE; Buescher ES
J Infect Dis; 1990 Jul; 162(1):109-14. PubMed ID: 2192004
[TBL] [Abstract][Full Text] [Related]
13. The beneficial effects of immunostimulation in posttraumatic sepsis.
Austin OM; Redmond HP; Watson WG; Cunney RJ; Grace PA; Bouchier-Hayes D
J Surg Res; 1995 Oct; 59(4):446-9. PubMed ID: 7564315
[TBL] [Abstract][Full Text] [Related]
14. Results of a phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in very low birthweight neonates: significant induction of circulatory neutrophils, monocytes, platelets, and bone marrow neutrophils.
Cairo MS; Christensen R; Sender LS; Ellis R; Rosenthal J; van de Ven C; Worcester C; Agosti JM
Blood; 1995 Oct; 86(7):2509-15. PubMed ID: 7670096
[TBL] [Abstract][Full Text] [Related]
15. Protection against gram-negative bacteremia in neutropenic mice with recombinant granulocyte-macrophage colony-stimulating factor.
Bermudez LE; Martinelli JC; Gascon R; Wu M; Young LS
Cytokine; 1990 Jul; 2(4):287-93. PubMed ID: 1966550
[TBL] [Abstract][Full Text] [Related]
16. Modulation of neonatal myelopoiesis in newborn rats after 7 days' administration of either granulocyte-monocyte colony stimulating factor or interleukin-3.
Cairo MS; Mauss D; Plunkett JM; Gillis S; van de Ven C
Pediatr Res; 1991 May; 29(5):504-9. PubMed ID: 1896256
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor have differential effects on neonatal and adult neutrophil survival and function.
Molloy EJ; O'Neill AJ; Grantham JJ; Sheridan-Pereira M; Fitzpatrick JM; Webb DW; Watson RW
Pediatr Res; 2005 Jun; 57(6):806-12. PubMed ID: 15718363
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte-macrophage colony stimulating factor and Pneumocystis carinii pneumonia in mice.
Mandujano JF; D'Souza NB; Nelson S; Summer WR; Beckerman RC; Shellito JE
Am J Respir Crit Care Med; 1995 Apr; 151(4):1233-8. PubMed ID: 7697258
[TBL] [Abstract][Full Text] [Related]
19. G-CSF and GM-CSF for treating or preventing neonatal infections.
Carr R; Modi N; Doré C
Cochrane Database Syst Rev; 2003; 2003(3):CD003066. PubMed ID: 12917944
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte-macrophage colony-stimulating factor inhibits tumor growth during the postoperative period.
Hill AD; Redmond HP; Naama HA; Bouchier-Hayes D
Surgery; 1996 Feb; 119(2):178-85. PubMed ID: 8571203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
